4503 — Astellas Pharma Share News
0.000.00%
Last trade - 00:00Factbox: Trump's tariffs and threatened trade actions
Brief: Astellas And Pfizer's Xtandi™ (Enzalutamide) Shows Long-Term Overall Survival In Metastatic Hormone-Sensitive Prostate Cancer
Factbox: Trump's tariffs and threatened trade actions
Media: Astellas CEO says engaging with activist investor Farallon - Bloomberg News
Factbox: Trump's tariffs and threatened trade actions
Table: Astellas -2024/25 group results (IFRS)
Table: Astellas -2024/25 parent results
India's Zydus Life and Lupin fall on losing US patent case for bladder disorder drug
Factbox: Trump's tariffs and threatened trade actions
Factbox: Trump's tariffs and threatened trade actions
Factbox: Trump's tariffs and threatened trade actions
Brief: CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation
Factbox: Trump's tariffs and threatened trade actions
Brief: Astellas Pharma, Yaskawa Electric: Agree To Establish Joint Venture Focused On Cell Therapy Manufacturing
Factbox: Trump's tariffs and threatened trade actions
Factbox: All of Trump's tariffs and threatened trade actions
Factbox: All of Donald Trump's tariffs and threatened trade actions
Brief: Astellas Pharma Inc - U.S. FDA Approves Expanded Label For Astellas' Izervay(Avacincaptad Pegol Intravitreal Solution) For Geographic Atrophy
Brief: Farallon Capital Management Has Built More Than 3% Position In Astellas - FT